Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 5171-5177

  Hayman, James A ^a   Kabeto, Mohammed U ^a   Schipper, Matthew J ^a   Bennett, Jonathan E ^a   Vicini, Frank A ^a   Pierce, Lori J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PARTIAL MASTECTOMY; PATIENT ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; TREATMENT PLANNING; ADJUVANT THERAPY; BREAST TUMOR; CANCER INVASION; COST BENEFIT ANALYSIS; FOLLOW UP; MIDDLE AGED; PAGET NIPPLE DISEASE; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 24644510359     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.692     Document Type: Article

References (24)

1. American Cancer Society: Cancer Facts and Figures 2003. Atlanta, GA, American Cancer Society, 2003
2. Ernster VL, Ballard-Barbash R, Barlow WE, et al: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554, 2002
3. Innos K, Horn-Ross PL: Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer 97:1099-1106, 2003
4. Winchester DJ, Menck HR, Winchester DP: National treatment trends for ductal carcinoma in situ of the breast. Arch Surg 132:660-665, 1997
5. Silverstein MJ, Lagios MD: Benefits of irradiation for DCIS: A Pyrrhic victory. Lancet 355:510-511, 2000
6. Fisher B, Land S, Mamounas E, et al: Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28:400-418, 2001
7. Houghton J, George WD, Cuzick J, et al: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 362:95-102, 2003
8. Julien JP, Bijker N, Fentiman IS, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853-EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533, 2000
9. Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 5:1-29, 1986
10. Weinstein MC, Siegel JE, Gold MR, et al: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276:1253-1258, 1996
11. Earle CC, Chapman RH, Baker CS, et al: Systematic overview of cost-utility assessments in oncology. J Clin Oncol 18:3302-3317, 2000
12. Russell LB, Gold MR, Siegel JE, et al: The role of cost-effectiveness analysis in health and medicine. JAMA 276:1172-1177, 1996
13. Hayman JA, Fairclough DL, Harris JR, et al: Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 15:1252-1260, 1997
14. Furlong W, Feeny D, Torrance G: Guide to the Design and Development of Health-State Utility Instrumentation: Centre for Health Economics and Policy Analysis Working Paper. Hamilton, Ontario, Canada, McMaster University, 1990
15. Sumner W, Nease R, Littenberg B: U-titer: A utility assessment tool. Proc Annu Symp Corn-put Appl Med Care 701-705, 1991
16. Sumner W, Nease R, Littenberg B: U-titer: A utility assessment tool. Proc Annu Symp Corn-put Appl Med Care 701-705, 1991
17. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998
18. Weinstein MC, Feinberg HV: Clinical Decision Analysis. Philadelphia, PA, W.B. Saunders, 1982
19. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
20. Hollander M, Wolfe DA: Nonparametric Statistical Methods (ed 2). New York, NY, John Wiley & Sons, Inc, 1999
21. Dolan P: Whose preferences count? Med Decis Making 19:482-486, 1999
22. Ubel PA, Loewenstein G, Jepson C: Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 12:599-607, 2003
23. Chan JL, Kabeto MU, Oldread AE, et al: The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma. Int J Radiat Oncol Biol Phys 53:934-941, 2002
24. Tengs TO, Wallace A: One thousand health-related quality-of-life estimates. Med Care 38:583-637, 2000